Abstract
Noscapine is an isoqiunoline alkaloid found in opium latex. Unlike most other alkaloids obtained from opium latex, noscapine is not sedative and has been used as antitussive drug in various countries. Recently, it has been introduced as an anti-mitotic agent. This drug can be used orally .When the resistance to other anti-cancer drugs such as paclitaxel menifests, noscapine might be effective. Therefore, noscapine and its analogs have great potential as novel anticancer agents.
Keywords: Noscapine, antitussive, anti-cancer, anti-mitotic, apoptosis
Recent Patents on Anti-Cancer Drug Discovery
Title: The Anti-Cancer Activity of Noscapine: A Review
Volume: 4 Issue: 1
Author(s): Massoud Mahmoudian and Parvaneh Rahimi-Moghaddam
Affiliation:
Keywords: Noscapine, antitussive, anti-cancer, anti-mitotic, apoptosis
Abstract: Noscapine is an isoqiunoline alkaloid found in opium latex. Unlike most other alkaloids obtained from opium latex, noscapine is not sedative and has been used as antitussive drug in various countries. Recently, it has been introduced as an anti-mitotic agent. This drug can be used orally .When the resistance to other anti-cancer drugs such as paclitaxel menifests, noscapine might be effective. Therefore, noscapine and its analogs have great potential as novel anticancer agents.
Export Options
About this article
Cite this article as:
Mahmoudian Massoud and Rahimi-Moghaddam Parvaneh, The Anti-Cancer Activity of Noscapine: A Review, Recent Patents on Anti-Cancer Drug Discovery 2009; 4 (1) . https://dx.doi.org/10.2174/157489209787002524
DOI https://dx.doi.org/10.2174/157489209787002524 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Drug Targeting to the Brain - A Review
Current Nanoscience Role of Inflammatory Mediators in Angiogenesis
Current Drug Targets - Inflammation & Allergy Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening Approaches to Improve Cellular Retention of Radiohalogen Labels Delivered by Internalising Tumour-Targeting Proteins and Peptides
Current Medicinal Chemistry Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy
Current Pharmaceutical Design Triterpenoids for Cancer Prevention and Treatment: Current Status and Future Prospects
Current Pharmaceutical Biotechnology Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Current Cancer Drug Targets Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Aquaporins and Glia
Current Neuropharmacology Characteristics of Brain Tumor Stem Cells and the Rationale for Applying Tyrosine Kinase Inhibitors as Potential Targeting Agents
Recent Patents on Regenerative Medicine Active-Targeted Nanotherapy Strategies for Prostate Cancer
Current Cancer Drug Targets EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Recent Developments in Taxane Drug Delivery
Current Drug Delivery PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging
Current Protein & Peptide Science Mutagenic Approaches to Modifying Gap Junction Phenotype
Current Drug Targets A Common Pathway for All Autoimmune Diseases? The Unholy Alliance of Environment, Cell Death and Nucleic Acids
Current Immunology Reviews (Discontinued)